The trend: Budget pressures, increased GLP-1 drug adoption, evolving government policies, and a growing preference for healthy eating are reshaping consumer grocery habits—forcing CPG giants like PepsiCo to rethink their strategy in order to remain competitive.
The situation: While PepsiCo had a solid Q2, beating expectations for both revenues and profits, its North American business remains challenged as consumers—whether on GLP-1s or not—cut back on snacks and sugary drinks and prioritize value.
GLP-1 use hits grocery spending: Pepsi, like many food companies, has been understandably measured about the impact GLP-1s are having on sales. Still, there are indications that their growing adoption is taking a toll. Food spending among GLP-1 users has declined by over $6.5 billion, according to a report from Big Chalk Analytics, with some categories vulnerable to volume declines of as much as 2.9%.
Make America healthy again: With both government agencies and consumers eyeing product labels more closely, Pepsi—along with the broader CPG industry—is moving quickly to remove contentious ingredients like artificial dyes, while ramping up its “functional” assortment.
Our take: The food industry is in a state of flux, with companies frantically adjusting their portfolios to accommodate shifts in eating and drinking behaviors. Speed is of the essence—brands must adapt to consumer demand for high-protein products and simplified labels.
Still, offering the right products alone isn’t enough. Without a compelling value proposition, brands risk losing ground to private labels and health-focused upstarts, especially as tariffs strain buying power.
Go further: Read our report on the Impact of Weight Loss Drugs 2025.
You've read 0 of 2 free articles this month.
One Liberty Plaza9th FloorNew York, NY 100061-800-405-0844
1-800-405-0844sales@emarketer.com